# Diamyd Medical sets up vaccine manufacturing facility in Umeå

Diamyd Medical is setting up a new manufacturing facility in Umeå, Sweden, to produce recombinant GAD65 for its diabetes vaccine Diamyd. Initial investments are estimated at approximately SEK 20 million (about USD 2 million).

- Type: New facility
- Announced: 2020-04-16
- Where: Umeå, Sweden, Sweden
- Value: $2.00M (20.0M SEK)
- Status: announced
- Capacity: 10,000 square foot site
- Products: recombinant GAD65, therapeutic diabetes vaccine Diamyd
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Diamyd Medical](https://endata.com/companies/46622.md)

## Sources

- [prnewswire.com](https://www.prnewswire.com/news-releases/diamyd-medical-opens-up-for-vaccine-manufacturing-in-umea-sweden-301042140.html), 2020-04-16: "The importance of being in control of your own manufacturing process has never been higher."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.